JFC [JPMORGAN CHINA REGION FUND] N-CSR: (Original Filing)

[ITEM 1. REPORTS TO STOCKHOLDERS. This report, including the financial statements herein, is sent to the stockholders of the Fund for their information. It is not a prospectus, circular or representation intended for use in the purchase or sale of shares of the Fund or of any securities mentioned in this report. Annual Report December 31, 2013 Objectives 1 Management] [EX-99 COD ETH 2 Principal Financial Officers IX. SARBANES OXLEY CODE OF ETHICS 1. Covered Officers/ Purpose of the Code a. i. Honest and ethical conduct, including the ethical handling of actual or apparent conflicts of interest between personal and professional relationships; ii. iii. iv. The prompt internal reporting of violations of this Sarbanes-Oxley Code of Ethics to an appropriate] [CERTIFICATIONS I, Simon Crinage, President of the JPMorgan China Region Fund, Inc., certify that: 1. 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect] [I, Simon Crinage, certify that: 1. 2. Simon Crinage March 7, 2014 I, Michael J. James, certify that: 1. 2. Michael J. James Treasurer and Principal Financial Officer of the JPMorgan China Region Fund, Inc. March 7, 2014]

By | 2016-03-28T22:10:17+00:00 March 7th, 2014|Categories: Chinese Stocks, JFC, SEC Original|Tags: , , , |0 Comments

MR [Mindray Medical International] 6-K: (Original Filing)

[Mindray Announces ADS Dividend Record Date for March 2014 Dividend SHENZHEN, China, March 7, 2014 — Mindray Medical International Limited (“Mindray”, NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today that, in accordance with NYSE rules, holders of record of Mindray ADSs at the close of business on March 14, 2014 are entitled to the] [3 EX-99.1 4]

MR [Mindray Medical International] 6-K: Mindray Announces ADS Dividend Record Date for March

[Mindray Announces ADS Dividend Record Date for March 2014 Dividend SHENZHEN, China, March 7, 2014 — Mindray Medical International Limited (“Mindray”, NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today that, in accordance with NYSE rules, holders of record of Mindray ADSs at the close of business on March 14, 2014 are entitled to the] [3 EX-99.1 4]

GAME [Shanda Games] 6-K: (Original Filing)

[Shanda Games Announces Retention of Special Committee Financial Advisor HONG KONG, March 6, 2014 As previously announced, the Proposal contemplates Shanda Interactive Entertainment Limited, the controlling shareholder of the Company, and an affiliate of Primavera Capital Limited (together, the “Consortium”) and other persons which may join the Consortium, acquiring the Company for US$3.45 per class A or class B ordinary] []

By | 2016-04-03T10:57:29+00:00 March 7th, 2014|Categories: Chinese Stocks, GAME, SEC Original|Tags: , , , , , |0 Comments

GAME [Shanda Games] 6-K: Shanda Games Announces Retention of Special Committee Financial

[Shanda Games Announces Retention of Special Committee Financial Advisor HONG KONG, March 6, 2014 As previously announced, the Proposal contemplates Shanda Interactive Entertainment Limited, the controlling shareholder of the Company, and an affiliate of Primavera Capital Limited (together, the “Consortium”) and other persons which may join the Consortium, acquiring the Company for US$3.45 per class A or class B ordinary] []

By | 2016-04-03T10:58:55+00:00 March 7th, 2014|Categories: Chinese Stocks, GAME, Webplus ver|Tags: , , , , , |0 Comments

ONP [Orient Paper] SC 13D/A: (Original Filing)

[_______________________________ SCHEDULE 13D (Amendment No. 1**) Orient Paper, Inc. *** (Name of Issuer) Common Stock (Title of Class of Securities) 68619F205 (CUSIP Number) August 31, 2009 (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and]

ONP [Orient Paper] SC 13D/A: _______________________________ SCHEDULE 13D (Amendment No. 1**) Orient Paper,

[_______________________________ SCHEDULE 13D (Amendment No. 1**) Orient Paper, Inc. *** (Name of Issuer) Common Stock (Title of Class of Securities) 68619F205 (CUSIP Number) August 31, 2009 (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and]

Skip to toolbar